The cost-effectiveness of the Strongest Families Neurodevelopmental Program. Aranie Vijayaratnam, University of Toronto and Technology Assessment at Sick Kids (TASK) MSc candidate, CHILD-BRIGHT Annual Meeting, Toronto, June 2023.
A cost effectiveness analysis of “Mega Team” for cognitive rehabilitation in ADHD. Roaa Shoukry, University of Toronto and Technology Assessment at Sick Kids (TASK) MSc candidate, CHILD-BRIGHT Annual Meeting, Toronto, June 2023.
HTA in Childhood Diseases: Methodologic challenges in conducting cost-effectiveness analysis. Health Technology Assessment International (HTAi) webinar, April 2022.
Economic evaluation of exome and genome sequencing in child health: Tracing the sequence from microcosting to implementation. Canadian Agency for Drugs and Technologies in Health, November 2021.
Supporting Early Social & Communication Development through Parent Coaching. Autism Training Community (ACT), April 2021.
23 and (not just) Me: Incorporating family members in health technology assessment of genetic testing. Network of Alberta Health Economists (NOAHE) Health Economics and Technology Assessment Rounds, Live Webinar, December 2020
In an era of biosimilars, can originator infliximab pricing remain competitive in treating inflammatory bowel disease? Naaz Bashir, Ph.D., post-doctoral fellow, Technology Assessment at Sick Kids (TASK), 2020.
Examining the price of infliximab in economic evaluations in inflammatory bowel disease, Naaz Bashir, Ph.D., post-doctoral fellow, Technology Assessment at Sick Kids (TASK), 2020.
Cost-effectiveness and clinical outcomes of early anti-tumor necrosis factor-α intervention in pediatric Crohn’s disease, Bashir NS, Walters TD, Griffiths AM, Ito S, Ungar WJ. Inflammatory Bowel Diseases, 26(8):1239-1250, 2020.
The 3-I framework: Considerations for developing regulations for direct-to-consumer genetic testing in Canada., Alex Cernat, University of Toronto and Technology Assessment at Sick Kids (TASK) MSc graduate, October 2020.
Former students share their best wishes and congratulations to their mentor, Dr. Wendy Ungar, upon her receipt of the 2020 Dr. Jill M. Sanders Award of Excellence in Health Technology Assessment from CADTH, November 2020.
Economic Evaluation in Child Health: Autism Spectrum Disorder. Children’s Healthcare Canada, Spark: Live Webinar Series, March 2020.
23 and (not just) me: Incorporating family members in health technology assessment of genetic testing. Toronto, February 7, 2020.
Services Used by Families with a Child with Autism. Autism Festival, Montreal, May 2019.
Autism Spectrum Disorder: A Tale of Two Provinces. Smith IM, Flanagan HE, Ungar WJ, D’Entremont B, Garon N, den Otter J, Waddell C, Bryson SE, Tsiplova K, Léger, N, Vezina F, Murray P. March 2019.
How accurate is the Modified Checklist for Autism in Toddlers? Description of Yuen T, Penner M, Carter MT, Szatmari P, Ungar WJ. Assessing the accuracy of the Modified Checklist for Autism in Toddlers: A systematic review and meta-analysis. Developmental Medicine and Child Neurology, 60(11): 1093-1100, 2018 (Featured as Editor’s Choice).
Where does the money go? Shifting the curve in early autism intervention. TEDx YorkUSalon Autism Innovations, Toronto, April 2017.
Pathways in ASD Study – A family’s story. Winner, 2017 CIHR Institute of Human Development, Child and Youth Health Talks Video Competition. P. Szatmari, T. Bennett, M. Chalupka, E. Duku, M. Elsabbagh, S. Georgiades, P. Mirenda, I. Smith, WJ. Ungar, T. Vaillancourt, J. Volden, C. Waddell, L. Zwaigenbaum. November 2017.
Access to Prescription Drugs for Canadian Children. A video module for the Canadian Institute of Child Health. January 2016.
A Physician Walks into My Office – A Day in the Life of W. Ungar, Health Economist. April 2015.